BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Surface Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-02-11 5:10 pm Sale |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-2,125,650![]() (Position Closed) |
Filing |
2020-05-29 5:06 pm Purchase |
2020-05-19 | 13G | Surface Oncology, Inc. SURF |
BIOTECHNOLOGY VALUE FUND L P | 2,125,650 5.800% |
2,125,650![]() (New Position) |
Filing |